menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'Cardiovascular' ×
Barbara Gillespie
A follow-up report on the CardioVascular Clinical Trialists Forum, and the opportunities to enhance collaboration between cardiologists, endocrinologists, and nephrologists for the benefit of patients with chronic kidney disease.
Read More
Alan Frederickson
How wearable glucose monitoring devices could change the way diabetes trials are conducted.
Read More
Barbara Gillespie
This year’s CVCT forum is dedicating a session towards understanding the evidence gaps for CV drugs in chronic kidney disease (CKD) patients.
Read More
Melanie Blackwood
How this global heart disease registry is providing key insights into global Atrial Fibrillation patient journey, and demonstrating the power of registries to change the care paradigm.
Read More
Rick Turner
High blood pressure, also known as hypertension, is an enormous medical problem in the United States and around the world, likely impacting directly or through family members virtually everyone we interact with on a daily basis.  Its reach is staggering; affecting about 70 million adults in the United States (that’s one in every three adults), and about 1 billion people worldwide.  It is a leading cause of heart attacks, strokes, heart failure, and death, and associated healthcare costs run close to $50 billion each year in the United States alone.  Despite the multitude of available drugs proven to lower blood pressure successfully when used properly, the elevated blood pressure of roughly half of affected people in the US is still not considered well controlled.  There are...
Read More